This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
FDA.FDA Drug Safety Communication: New contraindication and updated warning on kidney impairment for Reclast (zoledronic acid). Internet Document: [2 pages], 30 Aug 2011. Available from: URL: http://www.fda.gov
About this article
Cite this article
New contraindication added to Reclast drug label. React. Wkly. 1368, 3 (2011). https://doi.org/10.2165/00128415-201113680-00007
- Public Health
- Renal Function
- Renal Failure
- Serum Creatinine